GLIVEC

This brand name is authorized in Australia, Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, Spain, Turkey, UK.

Active ingredients

The drug GLIVEC contains one active pharmaceutical ingredient (API):

1	Imatinib UNII 8A1O1M485B - IMATINIB MESYLATE
	Imatinib is a protein-tyrosine kinase inhibitor which potently inhibits the Bcr-Abl tyrosine kinase at the in vitro, cellular and in vivo levels.
	Read more about Imatinib

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
GILVEC Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01EA01	Imatinib	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EA BCR-ABL tyrosine kinase inhibitors
Discover more medicines within L01EA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11752M, 11753N, 11758W, 11762C, 11765F, 11769K, 11775R, 11778X, 11780B, 11781C, 11784F, 11785G, 11786H, 11787J, 11788K, 11789L, 11878E, 11880G, 5443L, 5444M, 9111M, 9112N, 9113P, 9114Q, 9115R, 9116T, 9123E, 9124F, 9172R, 9173T, 9174W, 9175X, 9176Y, 9177B, 9178C, 9179D
BR	Câmara de Regulação do Mercado de Medicamentos	526507102113210, 526507103111211
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00189109, 00491943, 01685603, 01755166, 01755195, 01755203, 01810988, 02759574, 03560892, 04980248, 05497815, 05558801, 06140127, 06140133, 06846353, 08599321, 08880791, 09743926, 10843745, 11126856, 11606473, 12726305, 13167339, 13331862, 13781909, 13824978, 13889624, 14385038, 15786644, 16151221, 16151238, 16808017, 16808023, 17602329
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	23.892-1-06-11, 25.438-11-03
EE	Ravimiamet	1085677, 1085688, 1085699, 1085701, 1085712, 1085723, 1209798, 1209800, 1209811, 1209822, 1209833, 1209844, 1209855
ES	Centro de información online de medicamentos de la AEMPS	01198008, 01198010
FI	Lääkealan turvallisuus- ja kehittämiskeskus	085826
FR	Base de données publique des médicaments	63485353, 64936439
GB	Medicines & Healthcare Products Regulatory Agency	73199, 80897
HK	Department of Health Drug Office	49431
IE	Health Products Regulatory Authority	88550, 88581
IL	מִשְׂרַד הַבְּרִיאוּת	4854, 4855
IT	Agenzia del Farmaco	035372059
JP	医薬品医療機器総合機構	4291011F1028
LT	Valstybinė vaistų kontrolės tarnyba	1007379, 1008767, 1028663, 1028664, 1028665, 1028666, 1028667, 1028668, 1028669, 1028670, 1028671, 1028672, 1028673, 1056526, 1088010, 1088011, 1088012
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	498M2003
NG	Registered Drug Product Database	A4-9056
NL	Z-Index G-Standaard, PRK	60097, 71293, 71307
NZ	Medicines and Medical Devices Safety Authority	11140, 11141
PL	Rejestru Produktów Leczniczych	100080415, 100080591, 100105262, 100105279
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64766001, W64766002, W64766003, W64766004, W64766005
SG	Health Sciences Authority	13279P, 13280P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504093063, 8699504093070